AN
AnhCo Nguyen
President and CEO

AnhCo Nguyen insider trades: Atara Biotherapeutics (ATRA) stock sales

President and CEO, Atara Biotherapeutics Last trade Aug 17, 2026 16 Form 4 filings
$142K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where AnhCo reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 17, 2026ATRA↓ Sell$41K
May 18, 2026ATRA↓ Sell$48K
Mar 2, 2026ATRA↓ Sell$15K
Nov 17, 2025ATRA↓ Sell$38K
Aug 18, 2025ATRA↓ Sell$34K
May 16, 2025ATRA↓ Sell$22K
Mar 3, 2025ATRA↓ Sell$23K
Nov 18, 2024ATRA↓ Sell$19K
Aug 16, 2024ATRA↓ Sell$12K
May 16, 2024ATRA↓ Sell$26K
Mar 4, 2024ATRA↓ Sell$8K
Nov 16, 2023ATRA↓ Sell$3K
Aug 16, 2023ATRA↓ Sell$25K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ATRA insiders

Open-market trades in the last 12 months

About AnhCo Nguyen's insider trades

AnhCo Nguyen is President and CEO at Atara Biotherapeutics (ATRA). Since Aug 16, 2023, AnhCo has reported no open-market purchases and 13 sales worth $316K on SEC Form 4. In the last 12 months: 4 sales ($142K).

Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.